Donoghoe Nicholas

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 25% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Donoghoe Nicholas's trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
17.90
Quantity 63,810 -16.6%
Value US$4,065,052
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
241.71
Quantity 92,483
Value US$4,127,132
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
79.42
Quantity 10,878 -35.1%
Value US$1,947,590
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
198.27
Quantity 3,234 -4.5%
Value US$641,239
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
198.51
Quantity 13,299
Value US$2,639,966
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
176.30
Quantity 21,082 -27.4%
Value US$3,716,757
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
176.31
Quantity 21,082
Value US$3,716,941
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
176.31
Quantity 21,082
Value US$3,716,941
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
154.72
Quantity 2,912 -5.0%
Value US$450,545
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
154.73
Quantity 2,912
Value US$450,574
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-14
US Abbvie Inc (ABBV)
S Sale
63,810 -16.6%
17.90
US$4,065,052 		63,810 -16.6% 17.90 US$4,065,052
2026-08-14 2026-08-14
US Abbvie Inc (ABBV)
PrS Proposed sale
92,483
241.71
US$4,127,132 		92,483 241.71 US$4,127,132
2025-08-07 2025-08-05
US Abbvie Inc (ABBV)
S Sale
10,878 -35.1%
79.42
US$1,947,590 		10,878 -35.1% 79.42 US$1,947,590
2025-08-07 2025-08-05
US Abbvie Inc (ABBV)
S Sale
3,234 -4.5%
198.27
US$641,239 		3,234 -4.5% 198.27 US$641,239
2025-08-05 2025-08-05
US Abbvie Inc (ABBV)
PrS Proposed sale
13,299
198.51
US$2,639,966 		13,299 198.51 US$2,639,966
2024-03-22 2024-03-20
US Abbvie Inc (ABBV)
S Sale
21,082 -27.4%
176.30
US$3,716,757 		21,082 -27.4% 176.30 US$3,716,757
2024-03-21 2024-03-20
US Abbvie Inc (ABBV)
PrS Proposed sale
21,082
176.31
US$3,716,941 		21,082 176.31 US$3,716,941
2024-03-20 2024-03-20
US Abbvie Inc (ABBV)
PrS Proposed sale
21,082
176.31
US$3,716,941 		21,082 176.31 US$3,716,941
2023-12-28 2023-12-26
US Abbvie Inc (ABBV)
S Sale
2,912 -5.0%
154.72
US$450,545 		2,912 -5.0% 154.72 US$450,545
2023-12-26 2023-12-26
US Abbvie Inc (ABBV)
PrS Proposed sale
2,912
154.73
US$450,574 		2,912 154.73 US$450,574